PDL BioPharma (PDLI) Posts Q1 EPS of $0.04
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Financial Fact:
General and administrative expenses: 10.4M
Today's EPS Names:
BMNM, KG, NHC, More
Financial Fact:
General and administrative expenses: 10.4M
Today's EPS Names:
BMNM, KG, NHC, More
Join SI Premium – FREE
PDL BioPharma (NASDAQ: PDLI) reported Q1 GAAP EPS of $0.04, which may not compare to the analyst estimate of $0.05. Revenue for the quarter came in at $45.4 million versus the consensus estimate of $50.23 million.
For earnings history and earnings-related data on PDL BioPharma (PDLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- Revelation Biosciences (REVB) Misses Q2 EPS by 4c
- Evommune, Inc. (EVMN) Misses Q2 EPS by 20c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
